Ivy Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: compounded GLP-1 at one price for every dose, with a microdose option and no lab work
Ivy Rx scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
Price checked on Ivy Rx’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Ivy Rx is a telehealth brand that sells compounded semaglutide and tirzepatide injections, a lower-dose microdose line, and peptide therapies such as NAD+ and sermorelin. It advertises the same price at every dose, free shipping, same-day clinician review and no lab work, but exact plan prices appear only at checkout after the health questionnaire.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Ivy Rx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Ivy Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $175/mo (starting dose)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Ivy Rx
Each dimension is scored algorithmically from Ivy Rx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $175/mo (starting dose), Ivy Rx runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.0/10Ivy Rx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.2/10Ivy Rx treats patients in all 50 states.
Support10%
5.8/10Ivy Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Ivy Rx review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $175–$275/mo across 2 dose/plan tiers (checked July 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Ivy Rx
We walked Ivy Rx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a treatment (GLP-1 injections or microdose) on Ivy Rx's website and click Get Started.
- 2The online questionnaire opens, and the first screen asks how many pounds you want to lose.
- 3Ivy Rx's help center says the questionnaire is followed by account creation, a shipping address and a checkout where you choose a 4-week, 12-week, 6-, 9- or 12-month plan and pay before the doctor's review.
- Product pages show only a teaser price ('From $77 (4 doses/month)' for GLP-1, 'From $69' for microdose); the actual plan price is shown at checkout after the questionnaire.
- Pages promise 'Same price, every dose', 'Labwork isn't needed', same-day physician review and fast, free delivery.
- Per the help center, you pay at checkout before a physician reviews your answers.
- Refund terms conflict between the refund policy page, the FAQ and the terms of service.
- The site also sells NAD+, sermorelin, glutathione, BPC-157, metformin and supplements alongside GLP-1s.
Ivy Rx customer support
- Phone
- 866-464-8979
- support@ivyrx.com
GLP-1 medications Ivy Rx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Ivy Rx offers
Beyond GLP-1s, Ivy Rx also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Range up to $197/mo; plan prices are shown only at checkout after the questionnaire (plans from 4 weeks to 12 months)
Range up to $297/mo; plan prices are shown only at checkout after the questionnaire (plans from 4 weeks to 12 months)
Ready to get started?
Plans and promotions change often, so check Ivy Rx's current pricing and active discounts before you decide.
What we like
- Same price at every dose, so your cost doesn't climb as the dose goes up
- No lab work required and same-day clinician review
- Free, discreet shipping on all medications
- Offers both compounded semaglutide and tirzepatide, plus a microdose option
- Cancel anytime with no long-term commitment or cancellation fee, per its help center
- Large, active Trustpilot profile with a 4.7 rating from over 7,500 reviews
Watch-outs
- Advertises GLP-1 'from $77' a month, but real plan prices only appear at checkout after the questionnaire and account creation
- Refund rules conflict: one page says returns are not accepted, while the terms allow a refund request within 15 days
- Subscriptions auto-renew, and the terms let Ivy Rx raise prices at any time
- Compounded medications are not FDA-approved
- Brand-name Ozempic and Mounjaro are listed at $1,399 with no billing period stated
Ivy Rx: a flat-rate compounded GLP-1 shop that hides its real prices until checkout
Ivy Rx is a no-frills telehealth provider built around one idea that most patients care about: you pay the same price no matter how high your dose climbs. Where a lot of GLP-1 programs raise your bill every time your prescriber bumps your milligrams, Ivy Rx markets "same price, every dose." It also skips lab work and promises same-day clinician review. The main frustration is pricing transparency: you won't see the actual price of your plan until you've finished a long health questionnaire and created an account.
How the pricing works
Ivy Rx's product pages advertise GLP-1 injections "from $77" for four doses a month, without separating semaglutide from tirzepatide or saying which plan length that figure assumes. Checkout offers plans from 4 weeks to 12 months, so a teaser like that most likely reflects a long prepaid plan. We couldn't confirm the plan prices for this update. The last figures we confirmed put compounded semaglutide at $175 a month (starting dose) and compounded tirzepatide at $275 a month as starting rates. Treat those as a guide and check the exact number at checkout before you pay. Compare KIN Health, which posts its flat rates on the product page and names its three dispensing pharmacies. One caveat: it doesn't offer GLP-1 care in four states.
For context, that semaglutide figure sits right around the $179 median cheapest ongoing rate across the GLP-1 providers we track. The flat-rate promise is the important part: once you're on a medication, moving to a higher dose shouldn't change your monthly cost the way it does at dose-tiered competitors. One caution from the terms of service: subscriptions auto-renew, and Ivy Rx reserves the right to raise its subscription prices at any time.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
What's bundled into the price
- The medication itself
- The medical consultation and prescriber review, with no lab work required
- Free, discreet shipping on medications filled by its partner pharmacies
That bundle matters because some "cheap" programs tack on a separate consult fee or charge for shipping. Ivy Rx folds all three into the plan price, and its help center says there are no long-term commitments and no cancellation fees, so you can cancel anytime. Note that you pay at checkout before a physician reviews your answers.
The medications and how you get them
Ivy Rx's GLP-1 programs are compounded: versions of the same active ingredients as Wegovy, Ozempic, Zepbound, and Mounjaro, made by a compounding pharmacy. It also sells a lower-dose microdose line and peptide therapies such as NAD+, sermorelin, glutathione, and BPC-157. Brand-name Ozempic and Mounjaro appear on the site too, but with no billing period stated, so ask before assuming what you'd pay. Compounded GLP-1s are typically less expensive than brand drugs, but they aren't FDA-approved products and quality depends on the pharmacy behind them.
The process is an asynchronous online intake rather than a high-touch clinical relationship: a questionnaire of roughly 40 questions, account creation, checkout, then same-day clinician review. To keep your prescription renewing, you complete a monthly check-in; if you skip it, the system cancels the renewal.
What sets Ivy Rx apart, and what's missing
The main differentiator is dose-independent pricing on both of the most-wanted GLP-1 molecules, plus a microdose option and no lab requirement. Ivy Rx also has a large, active Trustpilot profile: 4.7 stars from more than 7,500 reviews. If a fast, low-friction start is your priority, that's a selling point.
The flip side is transparency. Beyond the hidden plan prices, Ivy Rx doesn't name the compounding pharmacies that fill its prescriptions. There is also Ozari Health, which lists its 503A pharmacies and the states each one serves. Worth knowing: its lowest prices require paying several months up front. Its refund rules also conflict: the refund policy page says returns aren't accepted, the FAQ says all transactions are final, and the terms of service allow a refund request by email within 15 days of your order. It says it works with licensed clinicians in all 50 states; confirm yours at sign-up.
Who should choose Ivy Rx, and who should skip it
- Good fit: patients who want a predictable, flat monthly cost as they titrate, no lab work, and a fast online process, and who are comfortable with compounded medication
- Good fit: people who want semaglutide, tirzepatide, and a microdose option from one provider without dose-based price creep
- Skip it if: you want to compare exact prices before handing over your health history and creating an account
- Skip it if: you need clear refund terms, hands-on clinical support, or a named pharmacy you can vet before committing
Trust, safety, and medical oversight
On the reassuring side, Ivy Rx has no FDA warning letters on file, displays a LegitScript seal on its site, and its programs include a prescriber review rather than selling medication with no clinical gate. On the cautious side, the unnamed pharmacy partners, conflicting refund language, and checkout-only pricing mean you're taking parts of the model on faith. The pragmatic move is to confirm the exact price and plan length for your drug, the pharmacy's name, and the refund terms in writing before your first order. You can see how we weigh these factors in our scoring methodology.
The bottom line
Ivy Rx is a mainstream way to get compounded semaglutide or tirzepatide at a flat rate that won't balloon as your dose rises, with the consult and shipping included and no labs required. That predictability and speed are its strongest cards. The drawback is that you can't see what you'll pay until checkout, and the refund rules contradict each other, so it earns a qualified recommendation for patients willing to do a little homework before they buy.
The Bottom Line
Ivy Rx scores highest on state availability and ease of access.
Ready to start with Ivy Rx?
From $175/mo (starting dose). See current pricing and start your free consultation.
Ivy Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Ivy Rx vs…
Ivy Rx scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Ivy Rx vs Amazon One Medical
Amazon One Medical scores 8.5/10

Ivy Rx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ivy Rx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Ivy Rx's current pricing
Plans from $175/mo (starting dose). Start your free consultation to check eligibility and today's price.